FDA Wouldn’t Defend Its Own Mifepristone Rule in Court
On Wednesday Louisiana asked the Fifth Circuit Court of Appeals to stop the abortion drug mifepristone from being mailed to patients by reinstating a rule that says you have to show up in person to get it. But if it wins, Louisiana told the three-judge panel, it doesn't want the rule change to go into effect immediately, because Louisiana doesn't trust the Supreme Court would let that restriction stand.
Meanwhile, the FDA showed up to oppose Louisiana in court but wouldn't answer a single question about its own rule. So the abortion pill manufacturers (who are now party to the mifepristone…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.